MedPath

Effect of unani formulation on dandruff

Phase 2
Conditions
Health Condition 1: null- Dandruff
Registration Number
CTRI/2017/08/009214
Lead Sponsor
Jamia Hamdard
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Clinically Diagnosed cases of Huzaz(dandruff)

Provided written informed consent willing to participate in complete test process

Patient using any other medication for dandruff will be included after washed out period of one week

Exclusion Criteria

Patient who fail to give consent

Patient who has any hair related disorder such as, Tinea capitis, contact dermatitis, alopecia areata and psoriasis

No hair perming or coloring in the last two months and promised no hair perming or coloring during the study period

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath